{
  "id": 1956166,
  "title": "Merck, Moderna Stocks Soar After Melanoma Trial Success",
  "url": "https://urgent.news/2026/08/19/merck-moderna-stocks-soar-after-melanoma-trial-success",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-19T14:27:14.000Z",
  "source": {
    "name": "Bloomberg",
    "slug": "bloomberg",
    "url": "https://www.bloomberg.com/news/videos/2026-08-19/merck-moderna-stocks-soar-after-melanoma-trial-success-video"
  },
  "original_language": "en",
  "account": null,
  "summary": "Shares of Moderna and Merck soared on Wednesday morning after a study showed that a vaccine they produced had promising results when it comes to fighting skin cancer. A late-stage trial showed that the mRNA vaccine helped reduce the recurrence of melanoma. Sam Fazeli of Bloomberg Intelligence has more. (Source: Bloomberg)",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}